EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study

Anouk H Eijkelboom, Linda de Munck, Marthe Larsen, Maarten J Bijlsma, Vivianne C G Tjan-Heijnen, Carla H van Gils, Mireille J M Broeders, Jan F Nygård, Marc B I Lobbes, Charles W Helsper, Ruud M Pijnappel, Luc J A Strobbe und 4 weitere

Cancer Epidemiology · 2023

DOI: 10.1016/j.canep.2023.102481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Epidemiology, 2023. Verfasst von Anouk H Eijkelboom und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, the Netherlands; Department of Resea…. Hauptthemen laut MEDLINE: Breast Neoplasms, COVID-19. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Comparing the impact of the COVID-19 pandemic on the incidence of newly diagnosed breast tumors and their tumor stage between the Netherlands and Norway will help us understand the effect of differences in governmental and social reactions towards the pandemic. METHODS: Women newly diagnosed with breast cancer in 2017-2021 were selected from the Netherlands Cancer Registry and the Cancer Registry of Norway. The crude breast cancer incidence rate (tumors per 100,000 women) during the first (March-September 2020), second (October 2020-April 2021), and Delta COVID-19 wave (May-December 2021) was compared with the incidence rate in the corresponding periods in 2017, 2018, and 2019. Incidence rates were stratified by age group, method of detection, and clinical tumor stage. RESULTS: During the first wave breast cancer incidence declined to a larger extent in the Netherlands than in Norway (27.7% vs. 17.2% decrease, respectively). In both countries, incidence decreased in women eligible for screening. In the Netherlands, incidence also decreased in women not eligible for screening. During the second wave an increase in the incidence of stage IV tumors in women aged 50-69 years was seen in the Netherlands. During the Delta wave an increase in overall incidence and incidence of stage I tumors was seen in Norway. CONCLUSION: Alterations in breast cancer incidence and tumor stage seem related to a combined effect of the suspension of the screening program, health care avoidance due to the severity of the pandemic, and other unknown factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCOVID-19FemaleHumansIncidencePandemicsNetherlandsNeoplasm StagingMass ScreeningNorway

Stichwörter der Autor:innen

Breast cancerCOVID-19IncidenceScreeningTumor stage

Autor:innen und Institutionen

  • Department of Health Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IK…
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands.
  • Section for Breast Cancer Screening, Cancer Registry of Norway, P.O. Box 5313, 0304 Oslo, Norway.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT Utrecht, the Netherlands; PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Ins…
  • Department of Medical Oncology, School for Oncology and Reproduction (GROW), Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.
  • Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG Utrecht, the Netherlands.

Zitieren

APA

Eijkelboom, A. H., de Munck, L., Larsen, M., Bijlsma, M. J., Tjan-Heijnen, V. C. G., van Gils, C. H., Broeders, M. J. M., Nygård, J. F., Lobbes, M. B. I., Helsper, C. W., Pijnappel, R. M., Strobbe, L. J. A., Wesseling, J., Hofvind, S., Siesling, S., & NABON-COVID-19 Consortium & The COVID and Cancer Care-NL Consortium (2023). Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2023.102481

Vancouver

Eijkelboom AH, de Munck L, Larsen M, Bijlsma MJ, Tjan-Heijnen VCG, van Gils CH, et al. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study. Cancer Epidemiology. 2023. doi:10.1016/j.canep.2023.102481

BibTeX
@article{Eijkelboom2023,
  author = {Eijkelboom, Anouk H and de Munck, Linda and Larsen, Marthe and Bijlsma, Maarten J and Tjan-Heijnen, Vivianne C G and van Gils, Carla H and Broeders, Mireille J M and Nygård, Jan F and Lobbes, Marc B I and Helsper, Charles W and Pijnappel, Ruud M and Strobbe, Luc J A and Wesseling, Jelle and Hofvind, Solveig and Siesling, Sabine and NABON-COVID-19 Consortium & The COVID and Cancer Care-NL Consortium, NABON-COVID-19 Consortium & The COVID and Cancer Care-NL Consortium},
  title = {Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study},
  journal = {Cancer Epidemiology},
  year = {2023},
  doi = {10.1016/j.canep.2023.102481}
}
Kostenlos starten →